Ferumoxytol-enhanced MRI differentiation of meningioma from dural metastases: a pilot study with immunohistochemical observations
Tóm tắt
Từ khóa
Tài liệu tham khảo
Weinstein JS, Varallyay CG, Dosa E et al (2010) Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review. J Cereb Blood Flow Metab 30:15–35
Dosa E, Tuladhar S, Muldoon LL, Hamilton BE, Rooney WD, Neuwelt EA (2011) MRI using ferumoxytol improves the visualization of central nervous system vascular malformations. Stroke 42:1581–1588
Christ GJ, Spray DC, el-Sabban M, Moore LK, Brink PR (1996) Gap junctions in vascular tissues. Evaluating the role of intercellular communication in the modulation of vasomotor tone. Circ Res 79:631–646
Domingues PH, Teodosio C, Ortiz J et al (2012) Immunophenotypic identification and characterization of tumor cells and infiltrating cell populations in meningiomas. Am J Pathol 181:1749–1761
http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=9818 . Accessed 26 Feb 2016
Maiuri F, Iaconetta G, de Divitiis O, Cirillo S, Di Salle F, De Caro ML (1999) Intracranial meningiomas: correlations between MR imaging and histology. Eur J Radiol 31:69–75
Bo L, Mork SJ, Nyland H (1992) An immunohistochemical study of mononuclear cells in meningiomas. Neuropathol Appl Neurobiol 18:548–558
Morantz RA, Wood GW, Foster M, Clark M, Gollahon K (1979) Macrophages in experimental and human brain tumors. Part 2: studies of the macrophage content of human brain tumors. J Neurosurg 50:305–311
Dejana E (1996) Endothelial adherens junctions: implications in the control of vascular permeability and angiogenesis. J Clin Invest 98:1949–1953
Arishima H, Sato K, Kubota T (2002) Immunohistochemical and ultrastructural study of gap junction proteins connexin26 and 43 in human arachnoid villi and meningeal tumors. J Neuropathol Exp Neurol 61:1048–1055
Long DM (1970) Capillary ultrastructure and the blood–brain barrier in human malignant brain tumors. J Neurosurg 32:127–144
http://www.fda.gov/Drugs/DrugSafety/ucm440138.htm . Accessed 3 March 2016